Centre for Pharmacology and Therapeutics, Experimental Medicine, Imperial College London, London, UK.
Circ Res. 2012 May 25;110(11):1423-34. doi: 10.1161/CIRCRESAHA.112.264473. Epub 2012 Apr 26.
RhoA and Rho kinase contribute to pulmonary vasoconstriction and vascular remodeling in pulmonary hypertension. RhoB, a protein homologous to RhoA and activated by hypoxia, regulates neoplastic growth and vasoconstriction but its role in the regulation of pulmonary vascular function is not known.
To determine the role of RhoB in pulmonary endothelial and smooth muscle cell responses to hypoxia and in pulmonary vascular remodeling in chronic hypoxia-induced pulmonary hypertension.
Hypoxia increased expression and activity of RhoB in human pulmonary artery endothelial and smooth muscle cells, coincidental with activation of RhoA. Hypoxia or adenoviral overexpression of constitutively activated RhoB increased actomyosin contractility, induced endothelial permeability, and promoted cell growth; dominant negative RhoB or manumycin, a farnesyltransferase inhibitor that targets the vascular function of RhoB, inhibited the effects of hypoxia. Coordinated activation of RhoA and RhoB maximized the hypoxia-induced stress fiber formation caused by RhoB/mammalian homolog of Drosophila diaphanous-induced actin polymerization and RhoA/Rho kinase-induced phosphorylation of myosin light chain on Ser19. Notably, RhoB was specifically required for hypoxia-induced factor-1α stabilization and for hypoxia- and platelet-derived growth factor-induced cell proliferation and migration. RhoB deficiency in mice markedly attenuated development of chronic hypoxia-induced pulmonary hypertension, despite compensatory expression of RhoA in the lung.
RhoB mediates adaptational changes to acute hypoxia in the vasculature, but its continual activation by chronic hypoxia can accentuate vascular remodeling to promote development of pulmonary hypertension. RhoB is a potential target for novel approaches (eg, farnesyltransferase inhibitors) aimed at regulating pulmonary vascular tone and structure.
RhoA 和 Rho 激酶可导致肺动脉高压中的肺血管收缩和血管重构。RhoB 是一种与 RhoA 同源且被低氧激活的蛋白,它调节肿瘤生长和血管收缩,但它在肺血管功能调节中的作用尚不清楚。
确定 RhoB 在低氧诱导的肺动脉内皮和平滑肌细胞反应以及慢性低氧诱导的肺动脉高压中的肺血管重构中的作用。
低氧增加了人肺动脉内皮和平滑肌细胞中 RhoB 的表达和活性,同时激活了 RhoA。低氧或组成型激活的 RhoB 的腺病毒过表达增加了肌动球蛋白收缩力,诱导内皮通透性,并促进细胞生长;显性负性 RhoB 或法呢基转移酶抑制剂(靶向 RhoB 的血管功能)抑制了低氧的作用。RhoA 和 RhoB 的协调激活最大限度地增加了由 RhoB/果蝇的 Diaphanous 同源物诱导的肌动蛋白聚合和 RhoA/Rho 激酶诱导的肌球蛋白轻链 Ser19 磷酸化引起的低氧诱导的应激纤维形成。值得注意的是,RhoB 特异性地需要低氧诱导因子-1α 的稳定以及低氧和血小板衍生生长因子诱导的细胞增殖和迁移。尽管在肺部中 RhoA 的表达代偿性增加,但在小鼠中 RhoB 的缺乏显著减弱了慢性低氧诱导的肺动脉高压的发展。
RhoB 介导血管对急性低氧的适应性变化,但慢性低氧的持续激活可加重血管重构,促进肺动脉高压的发展。RhoB 是一种潜在的靶点,可能为调节肺血管张力和结构的新方法(例如,法呢基转移酶抑制剂)提供新的靶点。